# Evaluate the Tolerance, Safety and Pharmacokinetics of Germinal Peptide Eye Drops in Healthy Volunteers

> **NCT03662971** · PHASE1 · COMPLETED · sponsor: **Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.** · enrollment: 42 (actual)

## Conditions studied

- Corneal Defect

## Interventions

- **DRUG:** Germinal peptide eye drops

## Key facts

- **NCT ID:** NCT03662971
- **Lead sponsor:** Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-29
- **Primary completion:** 2018-12-04
- **Final completion:** 2019-10-24
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2020-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03662971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03662971, "Evaluate the Tolerance, Safety and Pharmacokinetics of Germinal Peptide Eye Drops in Healthy Volunteers". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03662971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*